| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $340.1M | +1.5% | -11.1% |
| R&D Expense | $12.0M | +20.0% | -7.7% |
| SG&A Expense | $79.1M | -2.9% | -19.5% |
| Operating Income | -$60.6M | -10.5% | -14.9% |
| Interest Expense | $24.4M | -1.1% | -1.3% |
| Pre-tax Income | -$81.5M | -9.6% | -7.1% |
| Income Tax | -$21.5M | -30.4% | -35.8% |
| Net Income | -$60.0M | -3.7% | +0.5% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $119.0M | -3.2% | -29.3% |
| Inventory | $191.1M | +7.1% | +11.0% |
| Current Assets | $734.9M | -0.1% | +10.7% |
| Total Assets | $3.27B | -2.4% | -6.3% |
| Current Liabilities | $2.02B | +301.3% | +427.6% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $24.5M | — | — |
| Capital Expenditures | $90.1M | — | — |
| Investing Cash Flow | -$107.1M | — | — |
| Financing Cash Flow | -$4.5M | — | — |
| Free Cash Flow | -$65.6M | — | — |
| $1.54B |
| -0.1% |
| +0.3% |
| Total Liabilities | $3.00B | -0.8% | -0.6% |
| Stockholders' Equity | $210.2M | -20.8% | -48.7% |